Covered recipient · General Payments record
QURAT UL AIN RIAZ SIPRA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$833.33
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $261.42 | 11 |
| Education | $210.97 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $100.71 | 2 |
| SANOFI-AVENTIS U.S. LLC | $74.99 | 1 |
| SOBI, INC | $69.99 | 1 |
| PFIZER INC. | $43.86 | 2 |
| Gilead Sciences, Inc. | $26.17 | 1 |
| Sumitomo Pharma America, Inc. | $25.78 | 1 |
| Acerta Pharma LLC | $25.69 | 1 |
| Janssen Biotech, Inc. | $25.27 | 1 |
| Incyte Corporation | $23.46 | 1 |
| Daiichi Sankyo Inc. | $22.55 | 1 |
| Genentech USA, Inc. | $18.38 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $34.72 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139302408 | CMS |
| Astellas Pharma US Inc | $65.99 | 02/23/2024 | Education | Undisputed | 01/23/2026 | 1139344988 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.69 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104300288 | CMS |
| Daiichi Sankyo Inc. | $22.55 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089483951 | CMS |
| Genentech USA, Inc. | $18.38 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133091063 | CMS |
| Gilead Sciences, Inc. | $26.17 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133804212 | CMS |
| Incyte Corporation | $23.46 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141278220 | CMS |
| Janssen Biotech, Inc. | $25.27 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078283727 | CMS |
| Novartis Pharmaceuticals Corporation | $15.54 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087321611 | CMS |
| PFIZER INC. | $18.59 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131720442 | CMS |
| PFIZER INC. | $25.27 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131329367 | CMS |
| SANOFI-AVENTIS U.S. LLC | $74.99 | 05/10/2024 | Education | Undisputed | 01/23/2026 | 1139933886 | CMS |
| SOBI, INC | $69.99 | 02/09/2024 | Education | Undisputed | 01/23/2026 | 1141441185 | CMS |
| Sumitomo Pharma America, Inc. | $25.78 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148920925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.